Effects of intraperitoneal administration of free and liposome-entrapped doxorubicin on rat pesitoneal exudate cell populations

Journal of Drug Targeting

Volumn 4, Issue 4, 1996, Pages 255-264

  Storm, G ^a   Steerenberg, P A ^b   Van Borssum Waalkes, M ^a   Crommelin, D J A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Doxorubicin containing; Doxorubidcin; Intraperitoneal administration; Intraperitoneal chemotherapy; Intraperitoneal tumors; Liposomes; Mast cells; Peritoneal exudate cells; Peritoneal macrophages

Indexed keywords

CHOLESTEROL; DOXORUBICIN; LIPOSOME; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLSERINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL POPULATION; CONTROLLED STUDY; DRUG FORMULATION; ENDOCYTOSIS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAPERITONEAL DRUG ADMINISTRATION; MACROPHAGE; MAST CELL DEGRANULATION; NONHUMAN; PERITONEAL EXUDATE CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; RAT;

EID: 0029772651     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869608995627     Document Type: Article

References (26)

1. Blum, R.H. and Carter, S K. (1974) A new anticancer drug with significant clinical activity. Ann. Intern. Med., 80, 249-259.
2. Daemen, T., Hofstede, G., Ten Kate, M T., Bakker-Woudenberg, I.A.J.M and Scherphof, G.L. (1995) Liposomal doxorubicin-induced toxicity: depletion and impairment of phagocytic activity of liver macrophages Int. J. Cancer, 61, 716-721.
3. Delgado, G., Potkul, R.K., Treat, J.A,. Lewandowski, G.S., Barter, J.F., Forst, D. and Rahman, A. (1989) A phase I/II study of intraperitoneally administered doxorubicin entrapped in cardiolipin liposomes in patients with ovarian cancer. Am. J. Obstet. Gynecol., 160, 812-819.
4. Ehrke, M.J., Cohen, S.A. and Mihich, E. (1982) Selective effects of adriamycin on murine host defense systems. Immunol. Rev., 65: 55-78.
5. Fiske, C.H. and Subbarow, Y. (1925) The colorimetric determination of phosphorus. J. Biol. Chem., 66, 375-400.
6. Gabizon, A., Meshorer, A. and Barenholz, Y. (1986) Comparative long-term study of the toxicities of free and liposome-associated doxorubicin in mice after intravenous administration. J. Nat. Cancer Inst., 77, 459-469.
7. Ham, A. and Cormack, D.H. (1979) Histology, 8th Edition, JB Lippincott Company.
8. Hirano, K. and Hunt, C.A. (1985) Lymphatic transport of liposome-encapsulated agents: effects of liposome size following intraperitoneal administration. J. Pharm. Sci, 74, 915-921.
9. Howell, S.B. (1988) Intraperitoneal chemotherapy in ovarian cancer. Controversies in Oncology, 29, 72-83.
10. Lindhal, U., Pertoft, J. and Seljelid, R. (1979) Uptake and degradation of mast cell granules by mouse peritoneal macrophages. Biochem. J., 182, 189-193.
11. Markman, M. (1991) Intraperitoneal Chemotherapy. Semin. Oncol., 18, 248-254.
12. Martin, F., Caignard, A., Olsson, O., Jeannin, J.F. and Leclerc, A. (1982) Tumoricidal effect of macrophages exposed to adriamycin in vivo and in vitro. Cancer Res., 42, 3851-3857.
13. Mc Clay E.F. and Howell S.B. (1992) Intraperitoneal therapy in the management of patients with ovarian cancer. In Ozols, R.F. (ed), Hematology/Oncology Clinics of North America. Vol. 6: Ovarian Cancer, (Philadelphia: WB Saunders Company, Harcourt Brace Jovanovich, Inc.), pp. 915-926.
14. Meyers, C.E. (1982) Anthracyclines. In Chabner, B.(ed), Pharmacological principles of cancer treatment, W.B. Saunders Company, pp. 416-434.
15. Myers, C.E. (1984) The use of intraperitoneal chemotherapy in the treatment of ovarian cancer. Semin. Oncol., 11, 275-284.
16. Nässander, U.K., Storm, G., Peeters, P.A.M. and Crommelin, D.J.A. (1990) Liposomes. In Chasin M. and Langer R. (eds), Biodegradable Polymers as Drug Delivery Systems (New York: Marcel Dekker, Inc.), pp. 261-338.
17. 14C]cytosine β-d-arabinofuranoside following intraperitoneal administration to rats. Drug Metab. Dispos., 10, 40-46.
18. Patel, H.M., Parvez, N., Field, J. and Ryman, B.E. (1983) Lytic effect of heparin on liposomes: possible mechanism of lysis of red blood cells by heparin. Bioscience Rep., 3, 39-46.
19. Senior, J.H. (1987) Fate and behavior of liposomes in vivo: A review of controlling factors. CRC Crit. Rev. Ther. Drug Carrier Systems, 3, 123-193.
20. Storm, G , Van Bloois, L., Brouwer, M. and Crommelin, D.J.A. (1985) The interaction of cytostatic drugs with adsorbents in aqueous media. The potential implications for liposome preparation. Biochim. Biophys. Acta, 818, 343-351.
21. Storm, G., Roerdink, F.H., Steerenberg, P.A., De Jong, W.H. and Crommelin, D.J.A. (1987) Influence of lipid composition on the antitumor activity exerted by doxorubicin-containing liposomes in a rat solid tumor model. Cancer Res., 47, 3366-3372.
22. Storm, G., Regts, J., Beijnen, J.F. and Roerdink, F.H. (1989) Processing of doxorubicin-containing liposomes by liver macrophages in vitro. J. Liposome Res., 1, 195-210.
23. Storm, G., Nässander, U.K., Vingerhoeds, M.H., Steerenberg, P.A. and Crommelin, D.J.A. (1994) Antibody-targeted liposomes to deliver doxorubicin to ovarian cancer cells. J. Liposome Res., 4, 641-666.
24. Straubinger, R.M., Lopez, N.G., Debs, R.J., Hong, K. and Papahadjopoulos, D. (1988) Liposome-based therapy of human ovarian cancer: parameters determining potency of negatively charged and antibody-targeted liposomes. Cancer Res., 48, 5237-5245.
25. Vingerhoeds, M.H., Steerenberg, P.A., Hendriks, J.J.G.W., Dekker, L.C., Van Hoesel. Q.G.C.M, Crommelin, D.J.A. and Storm, G. (1996) Immunoliposome-mediated targeting of doxorubicin to human ovarian ovarian carcinomas in vitro and in vivo. Brit. J. Cancer, in press.
26. Williams, G.M. and Gunn JM. (1974) Longterm cell culture of adult rat liver epithelial cells. Exp. Cell Res., 89, 139-142.